1
Wong Vernon G, Hu Mae W L: Methods for treating inflammation-mediated conditions of the eye. Oculex Pharmaceuticals, Wong Vernon G, Hu Mae W L, sSHORTLE Rebecca, January 10, 2002: WO/2002/002076 (3 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


2
Wong Vernon G, Hu Mae W L, Berger Donald E Jr: Controlled-release biocompatible ocular drug delivery implant devices and methods. Oculex Pharmaceuticals, Wong Vernon G, Hu Mae W L, Berger Donald E Jr, SHORTLE Rebecca, May 3, 2001: WO/2001/030323 (2 worldwide citation)

Controlled release devices are disclosed which are biocompatible and can be implanted into the eye. The devices have a core comprising a drug and a polymeric outer layer which is substantially impermeable to the entrance of an environmental fluid and substantially impermeable to the release of the d ...